Hospital for Special Surgery Welcomes New CFO
Hospital for Special Surgery (HSS), a leader in the field of orthopedics and rheumatology, has appointed Christopher Dunleavy as its new Executive Vice President and Chief Financial Officer. This decision comes after a careful national search led by an experienced committee.
Leadership Transition at HSS
Christopher Dunleavy will officially take on his new role, succeeding Stacey Malakoff, who has dedicated nearly four decades to HSS. Malakoff's retirement marks the end of an era, and she will remain on board as a Senior Advisor until the end of the following year to ensure a smooth transition.
Experience That Matters
Dunleavy brings a wealth of experience from his previous positions at major healthcare providers, including Brigham Health and Baylor Health. His background also features work at USMD Holdings, demonstrating his capability in handling finances in complex health systems. His academic credentials are impressive; he holds an Executive MBA from Baylor University and has contributed to Harvard as a lecturer.
Visionary Leadership
HSS president and CEO Bryan Kelly emphasized Dunleavy's pivotal role in shaping the future of HSS's financial operations. He mentioned that after a thorough selection process, Dunleavy was the unanimous choice of the committee. His leadership is expected to invigorate the finance department, empowering HSS to advance in the evolving healthcare landscape.
The Future of Finance at HSS
In his new role, Dunleavy expressed enthusiasm about the prospects of making a significant impact on the field of medicine. He acknowledged HSS's world-renowned reputation and the financial resources at its disposal, poised to enhance musculoskeletal health. Dunleavy aims to build on Malakoff's legacy while steering the organization's next chapter of success.
Acknowledgments from HSS Leadership
HSS Surgeon-in-Chief, Dr. Douglas E. Padgett, applauded the inclusive leadership approach championed by Kelly, noting that collaborative efforts between medical and executive leaders facilitate better decisions. This approach further solidifies HSS’s efforts in advancing excellence across its operations.
About Hospital for Special Surgery
HSS stands as a premier academic medical center specializing in musculoskeletal health. It has been recognized as the No. 1 hospital in orthopedics for the last 15 years and continues to excel in rheumatology. HSS is dedicated to providing innovative patient care and is at the forefront of research and education in musculoskeletal health. The organization is committed to collaboration with various medical centers to improve the quality of care and widen access to its exceptional services both nationally and internationally.
Frequently Asked Questions
Who is Christopher Dunleavy?
Christopher Dunleavy is the newly appointed Chief Financial Officer of Hospital for Special Surgery, succeeding Stacey Malakoff.
What is HSS known for?
Hospital for Special Surgery is renowned as a leader in orthopedics and rheumatology, recognized for its excellence in patient care and research.
When will Dunleavy officially take over as CFO?
Christopher Dunleavy will officially assume his role as CFO on January 2, 2025.
How long has Stacey Malakoff worked at HSS?
Stacey Malakoff has dedicated nearly 40 years to HSS before announcing her retirement.
What is HSS’s commitment to research and education?
HSS is dedicated to advancing knowledge in musculoskeletal health through research, innovation, and educational initiatives.
